{"id":"https://openalex.org/W4361868783","doi":"https://doi.org/10.1158/1078-0432.22456092","title":"Supplemental Table 3 from The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-\u03baB","display_name":"Supplemental Table 3 from The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-\u03baB","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361868783","doi":"https://doi.org/10.1158/1078-0432.22456092"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22456092","doi":"https://doi.org/10.1158/1078-0432.22456092","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22456092","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_3_from_The_Novel_IKK2_Inhibitor_LY2409881_Potently_Synergizes_with_Histone_Deacetylase_Inhibitors_in_Preclinical_Models_of_Lymphoma_through_the_Downregulation_of_NF-_B/22456092/1/files/39907257.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_3_from_The_Novel_IKK2_Inhibitor_LY2409881_Potently_Synergizes_with_Histone_Deacetylase_Inhibitors_in_Preclinical_Models_of_Lymphoma_through_the_Downregulation_of_NF-_B/22456092/1/files/39907257.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101491956","display_name":"Changchun Deng","orcid":"https://orcid.org/0000-0001-9372-6086","observed_orcids":["https://orcid.org/0000-0001-9372-6086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Changchun Deng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057939557","display_name":"Mark R. Lipstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Lipstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071807274","display_name":"Xavier O. Jirau Serrano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier O. Jirau Serrano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084019868","display_name":"Christine M. Mcintosh","orcid":"https://orcid.org/0000-0003-3401-8914","observed_orcids":["https://orcid.org/0000-0003-3401-8914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine McIntosh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014482412","display_name":"Wei\u2010Yann Tsai","orcid":"https://orcid.org/0000-0002-5832-1400","observed_orcids":["https://orcid.org/0000-0002-5832-1400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei-Yann Tsai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021806378","display_name":"Andrew S. Wasmuth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew S. Wasmuth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049236815","display_name":"Susan Jaken","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Jaken","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Owen A. O'Connor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.02979999966919422,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.871999979019165},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9110000133514404},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.7323980331420898},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.7295359373092651},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.6890641450881958},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5506935119628906},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5190056562423706},{"id":"https://openalex.org/C13721689","wikidata":"https://www.wikidata.org/wiki/Q18033475","display_name":"HDAC3","level":5,"score":0.5065737962722778},{"id":"https://openalex.org/C2777730290","wikidata":"https://www.wikidata.org/wiki/Q411114","display_name":"NF-\u03baB","level":3,"score":0.4586484730243683},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.4388326406478882},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3879002332687378},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3811419606208801},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3432353138923645},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.2897234559059143},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17943069338798523},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1371384859085083},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.12304618954658508},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09281480312347412},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.066211998462677},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22456092","doi":"https://doi.org/10.1158/1078-0432.22456092","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22456092","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_3_from_The_Novel_IKK2_Inhibitor_LY2409881_Potently_Synergizes_with_Histone_Deacetylase_Inhibitors_in_Preclinical_Models_of_Lymphoma_through_the_Downregulation_of_NF-_B/22456092/1/files/39907257.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22456092.v1","doi":"https://doi.org/10.1158/1078-0432.22456092.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22456092.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22456092","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_Table_3_from_The_Novel_IKK2_Inhibitor_LY2409881_Potently_Synergizes_with_Histone_Deacetylase_Inhibitors_in_Preclinical_Models_of_Lymphoma_through_the_Downregulation_of_NF-_B/22456092","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22456092","doi":"https://doi.org/10.1158/1078-0432.22456092","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22456092","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_3_from_The_Novel_IKK2_Inhibitor_LY2409881_Potently_Synergizes_with_Histone_Deacetylase_Inhibitors_in_Preclinical_Models_of_Lymphoma_through_the_Downregulation_of_NF-_B/22456092/1/files/39907257.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361868783.pdf","grobid_xml":"https://content.openalex.org/works/W4361868783.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2013144228","https://openalex.org/W4361957998","https://openalex.org/W1979269885","https://openalex.org/W2170931794","https://openalex.org/W2514959459","https://openalex.org/W3025736062","https://openalex.org/W2563459633","https://openalex.org/W2080939719","https://openalex.org/W2534914495","https://openalex.org/W7096579867"],"abstract_inverted_index":{"Supplemental":[0],"Table":[1],"3.":[2],"Interaction":[3],"of":[4],"LY2409881":[5],"with":[6],"other":[7],"drugs/compounds":[8],"in":[9],"two":[10],"DLBCL":[11],"cell":[12],"line.":[13]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}